분획 혈류 예비력(FFR) : 시장 점유율 분석, 산업 동향 및 통계 데이터, 성장 예측(2026-2031년)

According to Mordor Intelligence, the fractional flow reserve market size is projected to be USD 1.16 billion in 2025, USD 1.28 billion in 2026, and reach USD 2.16 billion by 2031, growing at a CAGR of 11.03% from 2026 to 2031.

This report is Segmented by Product Type (Pressure-Wire FFR Systems, Micro-Catheter FFR Systems, and More), Sensor Technology (Optical Fiber, and More), Procedure Type (Diagnostic Coronary Angiography, and More), Modality (Invasive FFR, and More), End-User (Hospitals, and More), and Geography (North America, and More). Market Forecasts are Provided in Terms of Value (USD).

Global Fractional Flow Reserve Market Trends and Insights

Growing Prevalence of CAD

Coronary artery disease caused 19.8 million deaths in 2022, with three-quarters in low- and middle-income nations. Rapid urbanization and a doubling of diabetes prevalence across Asia-Pacific since 2000 are producing younger cohorts with diffuse disease that require physiology-based triage. Japan's share of citizens aged>= 65 reached 29% in 2024, pushing stable angina volumes higher.India's catheterization procedures jumped 34% between 2020 and 2024, yet only 15% used physiologic guidance, signaling sizable headroom for fractional flow reserve market penetration.Health systems are turning to both invasive pressure wires and outpatient FFR-CT to manage referrals without proportionate interventional expansion.

Guideline-Mandated FFR-Guided PCI

The 2024 ESC chronic coronary syndromes guideline and the 2025 ACC/AHA acute coronary syndromes update each granted Class I status to wire-based FFR for intermediate lesions, shifting payer logic toward physiology first. FLOWER-MI showed a 22% drop in major adverse events with FFR-guided complete revascularization versus angiography alone. Reimbursement denials for angiography-only PCI now prompt hospitals to stock pressure wires and train operators, while AI-driven angio-FFR offers a lower-cost path to meeting the mandate.

High Device and Software Cost

Single-use pressure wires cost USD 600-1,200, while FFR-CT licenses run USD 50,000-150,000 plus USD 300-500 per scan, challenging budgets where annual health spend per capita is under USD 200. Even U.S. hospitals face margin squeeze when inexperienced teams extend procedures beyond 60 minutes.

Other drivers and restraints analyzed in the detailed report include:

1. Rapid Adoption of Non-Invasive FFR-CT
2. Cost-Effectiveness vs Angiography-Only PCI
3. Limited Operator Skillset & Training

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Pressure-wire systems commanded 55.22% of fractional flow reserve market share in 2025, underscoring the entrenched role of disposable sensor wires in real-time decision making. Adoption remains strongest in academic and high-volume community hospitals where guideline mandates and operator familiarity sustain procedure volumes. The fractional flow reserve market size generated by these wires is expected to rise steadily as replacement cycles and training programs reinforce their procedural status. FFR-CT software, though starting from a smaller base, is projected to expand at a 15.24% CAGR through 2031 because outpatient imaging centers can now bill Medicare directly for physiology studies.

Radiology departments favor software because it defers invasive work-ups and cuts total episode costs, benefits that resonate with value-based purchasing. Early U.S. adopters report a 30% fall in unnecessary catheterizations after integrating FFR-CT into chest-pain workflows, a trend mirrored in Western Europe. Vendors are tailoring platforms for seamless plug-ins to existing CT scanners, reducing capital barriers for mid-sized centers. This bifurcation means wire-based systems will keep servicing complex, on-table decisions, while software platforms open new revenues in outpatient diagnostics rather than cannibalizing established volumes.

Optical-fiber pressure sensors delivered 46.52% of 2025 revenue thanks to electromagnetic immunity and long-term stability, qualities prized in catheterization laboratories. They anchor premium offerings such as Abbott's PressureWire X and Opsens' OptoWire, which combine thin profiles with quick signal fidelity. Hospitals value the reduced drift that limits recalibration and shortens procedure time, helping maintain throughput under fixed reimbursement schedules.

Micro-electromechanical-systems sensors are forecast to grow at 14.55% annually through 2031 as semiconductor manufacturing lowers unit cost toward USD 400 per wire and boosts supply for emerging markets. Boston Scientific's latest MEMS-based Comet wire cuts response time below 10 milliseconds, giving operators near-instant pressure feedback. The scalable economics appeal to health systems in Asia-Pacific and Latin America that face budget ceilings yet rising coronary-disease caseloads. As MEMS maturity narrows performance gaps, optical-fiber incumbents will defend share through ecosystem services, while mid-tier buyers migrate to lower-priced MEMS alternatives.

Complete Report Scope:

• By Product Type
  • Pressure-Wire FFR Systems
  • Micro-catheter FFR Systems
  • FFR-CT Software Platforms
  • Disposable Sensor Wires & Accessories
• By Sensor Technology
  • Optical Fiber Pressure Sensors
  • Piezoelectric / Strain-Gauge Sensors
  • MEMS-based Sensors
  • Other Emerging Sensors
• By Procedure Type
  • Diagnostic Coronary Angiography
  • Percutaneous Coronary Intervention (PCI)
• By Modality
  • Invasive FFR
  • Non-Invasive FFR-CT
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

List of Companies Covered in this Report:

1. Abbott Laboratories
2. ACIST Medical Systems
3. Asahi Intecc Co., Ltd.
4. Boston Scientific
5. Bracco Imaging S.p.A.
6. CathWorks Ltd.
7. GE Healthcare
8. HeartFlow, Inc.
9. Koninklijke Philips
10. Medtronic
11. MicroPort
12. Opsens Inc.
13. Pie Medical Imaging
14. PiezoWave Medical
15. Pulse Medical Imaging Technology
16. Shenzhen Rainmed Medical Technology
17. Siemens Healthineers
18. Terumo

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Prevalence of CAD
  • 4.2.2 Guideline-Mandated FFR-Guided PCI
  • 4.2.3 Rapid Adoption of Non-Invasive FFR-CT
  • 4.2.4 Cost-Effectiveness Vs. Angiography-Only PCI
  • 4.2.5 AI-Driven Real-Time Angio-FFR Analytics
  • 4.2.6 Emerging Reimbursement in Emerging Markets
• 4.3 Market Restraints
  • 4.3.1 High Device and Software Cost
  • 4.3.2 Limited Operator Skillset & Training
  • 4.3.3 Diagnostic Uncertainty in Micro-Vascular Disease
  • 4.3.4 Competitive Pressure From iFR/OFR Modalities
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value in USD)

• 5.1 By Product Type
  • 5.1.1 Pressure-Wire FFR Systems
  • 5.1.2 Micro-catheter FFR Systems
  • 5.1.3 FFR-CT Software Platforms
  • 5.1.4 Disposable Sensor Wires & Accessories
• 5.2 By Sensor Technology
  • 5.2.1 Optical Fiber Pressure Sensors
  • 5.2.2 Piezoelectric / Strain-Gauge Sensors
  • 5.2.3 MEMS-based Sensors
  • 5.2.4 Other Emerging Sensors
• 5.3 By Procedure Type
  • 5.3.1 Diagnostic Coronary Angiography
  • 5.3.2 Percutaneous Coronary Intervention (PCI)
• 5.4 By Modality
  • 5.4.1 Invasive FFR
  • 5.4.2 Non-Invasive FFR-CT
• 5.5 By End-User
  • 5.5.1 Hospitals
  • 5.5.2 Ambulatory Surgical Centers
  • 5.5.3 Diagnostic Imaging Centers
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 France
    • 5.6.2.3 United Kingdom
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 South Korea
    • 5.6.3.5 Australia
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.3.1 Abbott Laboratories
  • 6.3.2 ACIST Medical Systems
  • 6.3.3 Asahi Intecc Co., Ltd.
  • 6.3.4 Boston Scientific Corporation
  • 6.3.5 Bracco Imaging S.p.A.
  • 6.3.6 CathWorks Ltd.
  • 6.3.7 GE Healthcare
  • 6.3.8 HeartFlow, Inc.
  • 6.3.9 Koninklijke Philips N.V.
  • 6.3.10 Medtronic plc
  • 6.3.11 MicroPort Scientific
  • 6.3.12 Opsens Inc.
  • 6.3.13 Pie Medical Imaging
  • 6.3.14 PiezoWave Medical
  • 6.3.15 Pulse Medical Imaging Technology
  • 6.3.16 Shenzhen Rainmed Medical Technology
  • 6.3.17 Siemens Healthineers AG
  • 6.3.18 Terumo Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment